123435-97-2Relevant articles and documents
New straightforward route to an Huperzine A synthetic intermediate
Chassaing, Christophe,Haudrechy, Arnaud,Langlois, Yves
, p. 61 - 68 (1997)
A five step sequence of reactions afforded in high yield the tetrahydroquinoline derivative 3, a key intermediate in Huperzine A synthesis.
Development of a large-scale synthetic route to manufacture (-)-huperzine A
Tudhope, Stephen R.,Bellamy, Julie A.,Ball, Anthony,Rajasekar, Dewakar,Azadi-Ardakani, Manouchehr,Meera, Harihara Subramanian,Gnanadeepam, Jesudoss Mercy,Saiganesh, Ramanathan,Gibson, Frank,He, Linli,Behrens, Carl H.,Underiner, Gail,Marfurt, Judith,Favre, Nathalie
experimental part, p. 635 - 642 (2012/07/28)
A safe, practical and scalable process for manufacture of (-)-huperzine A has been developed and scaled up to manufacture several hundred grams of (-)-huperzine A with chemical and optical purity of >99%. The process consists of 11 chemical stages starting from commercially available materials with only nine isolation steps and no chromatography purification. This process provides a reliable and cost-effective source of synthetic (-)-huperzine A and its derivatives for pharmaceutical and nutraceutical markets.
Racemic huperzine A
-
Page 16, (2010/11/29)
The present invention relates to racemic huperzine A, a pharmaceutical composition comprising huperzine A, its use as a medicament and for the manufacture of a medicament for the inhibition of the cholesterase enzymes in a mammal.